A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis
Clinical trial NCT07237568 · RECRUITING
Trial details
- NCT number
- NCT07237568
- Sponsor
- Lynk Pharmaceuticals Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-29
- Primary completion
- 2026-11-01
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.